Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/21/2005EP1575940A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
09/21/2005EP1575936A1 Complexes of e-2-methoxy-n-(3-{4- [3-methyl-4-(6-methyl- pyridin -3-yloxy)-phenylamino] -quinazolin-6-yl}-allyl)-acetamide, their method of production, and use
09/21/2005EP1575933A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors
09/21/2005EP1575930A1 Novel retinol derivative and cosmetic composition comprising the same
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575924A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1575915A1 Modafinil polymorphic forms
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575903A1 Compounds for the inhibition of rotamases
09/21/2005EP1575673A2 Use of a trpm8-activating substance for the treatment of tumours
09/21/2005EP1575671A1 Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone
09/21/2005EP1575670A2 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia
09/21/2005EP1575639A2 Drug delivery system for sustained delivery of glipizide
09/21/2005EP1575619A1 Oligosaccharides and conjugates thereof for the treatement of pseudomonas bacteria infection
09/21/2005EP1575618A2 Dispersible pharmaceutical compositions
09/21/2005EP1575617A1 Use of topical pharmaceutical compositions comprising an active agent and permeation-enhancing base for the manufacture of a medicament to treat various forms of inflammatory dermatosis
09/21/2005EP1575616A2 Novel injectable depot formulations
09/21/2005EP1575600A1 Active ingredient combinations of polyhexamethylenebiguanidine hydrochloride and distearyldimethylammonium chloride and preparations comprising said active ingredient combinations
09/21/2005EP1575599A2 An agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component
09/21/2005EP1575598A1 Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
09/21/2005EP1575597A1 Use of rimexolone in the treatment of dry eye
09/21/2005EP1575596A1 Derivatives of prostaglandins for treating abdominal discomfort
09/21/2005EP1575595A1 Use of a combination containing a non-nucleoside reverse transcriptase inhibitor (nnrti) with an inhibitor of cytochrome p450, such as protease inhibitors
09/21/2005EP1575594A2 Combination of reboxetine and a cyclooxygenase-2 inhibitor
09/21/2005EP1575593A2 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders
09/21/2005EP1575591A1 Heterocycles and uses thereof
09/21/2005EP1575590A1 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
09/21/2005EP1575589A1 Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
09/21/2005EP1575588A1 Tiotropium containing hfc solution formulations
09/21/2005EP1575585A1 Pharmaceutical liquid composition containing pyridone derivative
09/21/2005EP1575584A2 Method of treating acute pain with a unitary dosage form comprising ibuprofen and oxycodone
09/21/2005EP1575583A1 Treatment of hiv infection through combined administration of tipranavir and capravirine
09/21/2005EP1575582A1 Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
09/21/2005EP1575581A1 Combinations of valsartan with cox-2 inhibitors
09/21/2005EP1575580A2 Method of treating cancers
09/21/2005EP1575579A2 Compositions comprising a combination of diphenyl urea impdh inhibitors and apoptosis-inducing anti-cancer agents
09/21/2005EP1575578A2 Methods of treating injuries of the nervous system associated with hemorrhage
09/21/2005EP1575577A2 Composition for the prevention and treatment of inflammation of the ear
09/21/2005EP1575576A2 Organic compounds
09/21/2005EP1575575A2 Safe chemical uncouplers for the treatment of obesity
09/21/2005EP1575574A2 Methods for treating and preventing apoptosis-related diseases using rna interfering agents
09/21/2005EP1575573A2 Agents and methods for treatment of disease by oligosaccharide targeting agents
09/21/2005EP1575569A2 Oral drug delivery system comprising high viscosity liquid carrier materials
09/21/2005EP1575567A1 Method and reagents for treating or preventing atherosclerosis and diseases associated therewith
09/21/2005EP1575566A1 Multilayer dosage forms containing nsaids and triptans
09/21/2005EP1575564A1 Solid dispersions comprising a hygroscopic and/or deliquescent drug
09/21/2005EP1575563A1 Non-hygroscopic formulation comprising a hydroscopic drug
09/21/2005EP1575559A1 Dosing aerosols containing lecithin as a surface-active substance
09/21/2005EP1575558A2 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium
09/21/2005EP1575557A1 Process for the chemical stabilization of a solubilized retinoid in a solvent using a base
09/21/2005EP1575556A2 Methods to administer epothilone d
09/21/2005EP1575555A2 Formulations of finasteride
09/21/2005EP1575552A2 Metal-containing materials, compositions and methods
09/21/2005EP1575549A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
09/21/2005EP1575547A2 Gel cleaning preparations comprising pre-gelatinised, cross-linked starch derivatives and polyacrylates
09/21/2005EP1575533A2 Topical compositions having a natural ingredient and method of use
09/21/2005EP1575532A2 Mixed esters of dicarboxylic acids for use as pigment dispersants
09/21/2005EP1575528A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
09/21/2005EP1575526A2 Dna vaccines encoding heat shock proteins
09/21/2005EP1575522A2 Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same
09/21/2005EP1575521A2 Pharmaceutical composition of 1-(3-hydroxy-4-methoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine and uses therof
09/21/2005EP1575519A2 Cd26-based therapies for cancers and immune disease
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575510A2 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
09/21/2005EP1575509A2 Epha2 agonistic monoclonal antibodies and methods of use thereof
09/21/2005EP1575506A2 Methods for improvement of lung function using tgf-beta inhibitors
09/21/2005EP1575503A2 Compositions and methods for treating and preventing infection
09/21/2005EP1575501A2 Use of amino acids for treatment of various conditions
09/21/2005EP1575494A2 Engineering absorption of therapeutic compounds via colonic transporters
09/21/2005EP1575493A2 Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
09/21/2005EP1575489A2 Use of inhibitors of soluble epoxide hydrolase to inhibit vascular smooth muscle cell proliferation
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1575481A2 Methods to increase or decrease bone density
09/21/2005EP1575478A2 A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
09/21/2005EP1575416A2 Methods of diagnosing and treating pre-eclampsia or eclampsia
09/21/2005EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque
09/21/2005EP1575379A1 Nutritional compositions
09/21/2005EP1575378A1 Pulverulent phytosterol formulations
09/21/2005EP1542728A4 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same
09/21/2005EP1509511B1 Manufacture of ascorbic acid esters
09/21/2005EP1461037A4 Beverage treated with nicotine
09/21/2005EP1450788B1 Use of coumarin or its hydroxy derivative for the treatment of medium or severe vascular and/or lymphatic edema
09/21/2005EP1438038A4 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
09/21/2005EP1435965A4 Pharmaceutical compositions and methods for treating cancer
09/21/2005EP1420790B1 Use of bibn4096 in combination with other antimigraine drugs for the treatment of migraine
09/21/2005EP1411961B1 Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
09/21/2005EP1406694A4 Electro-medical device for use with biologics
09/21/2005EP1401463B1 Compositions comprising thylakoids useful in the modulation of the inflammation process
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
09/21/2005EP1355641B1 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
09/21/2005EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/21/2005EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
09/21/2005EP1299382B1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
09/21/2005EP1296689B1 Method of administering bisphosphonates
09/21/2005EP1294679B1 Beta-amino acid nitrile derivatives
09/21/2005EP1282602B1 Propanoic acid derivatives as integrin receptor antagonists
09/21/2005EP1265862B1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/21/2005EP1263446B1 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
1 ... 4535 4536 4537 4538 4539 4540 4541 4542 4543 4544 4545 4546 4547 4548 4549 4550 4551 4552 4553 4554 4555 ... 7860